“Economic Analysis Of Unrelated Allogeneic Bone Marrow Transplantation: Results From The Randomized Clinical Trial Of T-Cell Depletion Vs Unmanipulated Grafts For The Prevention Of Graft-Versus-Host Disease.”. Bone Marrow Transplant 36 (6). Bone Marrow Transplant: 539-46. doi:10.1038/sj.bmt.1705078.
. 2005. “Blood And Marrow Transplant Clinical Trials Network (Bmt Ctn): Addressing Unanswered Questions”. Biol Blood Marrow Transplant 13. Biol Blood Marrow Transplant: 257-262. http://www.ncbi.nlm.nih.gov/pubmed/17317578.
. 2007. “Graft-Versus-Host Disease Treatment: Predictors Of Survival”. Biol Blood Marrow Transplant 16. Biol Blood Marrow Transplant: 1693-1699. http://www.ncbi.nlm.nih.gov/pubmed/20541024.
. 2010. “Mycophenolate Pharmacokinetics And Association With Response To Acute Graft-Versus-Host Disease Treatment From The Blood And Marrow Transplant Clinical Trials Network”. Biol Blood Marrow Transplant 16. Biol Blood Marrow Transplant: 421-429. http://www.ncbi.nlm.nih.gov/pubmed/19925875.
. 2010. “Peripheral-Blood Stem Cells Versus Bone Marrow From Unrelated Donors”. N Engl J Med 367. N Engl J Med: 1487-1496. http://www.ncbi.nlm.nih.gov/pubmed/23075175.
. 2012.